Résultats de la recherche - 55 results
The impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review
were searched until mid-September 2022 for studies focused on the impact of delayed CVD care due to the pandemic in Europe among adult patients. Outcomes were changes in hospital admissions, mortality ...
The direct disease burden of COVID-19 in Belgium in 2020 and 2021
model, using Belgian seroprevalence, social contact, hospital, and intensive care admission data, (b) deaths were sourced from the national COVID-19 mortality surveillance, and (c) chronic post-acute ...
Direct impact of COVID-19 by estimating disability-adjusted life years at national level in France in 2020
post-acute consequences, in 28 days (baseline) up to 140 days, following the initial infection. METHODS: National mortality, COVID-19 screening, and hospital admission data were used to calculate DALY s based ...
Epidemiology of COVID-19 mortality in Belgium from wave 1 to wave 7 (March 2020 – 11 September 2022)
between NH and hospitals. COVID-19 mortality rate The overall crude mortality rate (CMR) due to COVID-19 in Belgium, reached 281 per 100,000 inhabitants. It was higher in Wallonia (331 per 100,000 ...
Social inequalities and long-term health impact of COVID-19 in Belgium: protocol of the HELICON population data linkage
COVID-19 testing, infection, hospitalisations and mortality? Second, what is the medium-term and long-term health impact of COVID-19 infections and hospitalisations? More specific objectives are (2a) To ...
Homologous versus heterologous prime-boost COVID-19 vaccination: impact on clinical severity of Omicron among hospitalized COVID-19 patients in Belgium
in-hospital mortality, and severe COVID-19 – defined as experiencing an acute respiratory distress syndrome (ARDS) event, or an ICU transfer, or in-hospital mortality) for patients that received a homologous ...
Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium
estimate counterfactual risks for severe COVID-19 (combination of severity indicators), intensive care unit (ICU) admission, and in-hospital mortality under exposure to different vaccination schedules. The ...
Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
Joana Gomes Dias; Sonja J Olsen Source: Euro Surveill, Volume 28, Issue 4 (2023) Keywords: Aged Antiviral Agents Enzyme Inhibitors Guanidines Hospital Mortality Humans Influenza, Human Neuraminidase ...
Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis.
included 1077 cases of microbiologically confirmed secondary peritonitis. Mortality was 29.7%. The rate of appropriate empiric therapy showed no difference between survivors and non-survivors (66.4% vs. ...
Burden of non-communicable disease studies in Europe: a systematic review of data sources and methodological choices
(BoD) activities in Europe; (ii) collate information on data sources for mortality and morbidity; and (iii) provide an overview of NCD-specific methods for calculating NCD DALY s. Methods. NCD BoD studies ...